Home › Funds › CAISSE DE DEPOT ET PLACEMENT DU QUEBEC › GILD

CAISSE DE DEPOT ET PLACEMENT DU QUEBEC position in GILD

GILEAD SCIENCES INC · Health Care

CAISSE DE DEPOT ET PLACEMENT DU QUEBEC reported holding 1,835,851 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$273.6M, representing 0.40% of its reported portfolio and ranking #49 among its reported holdings. CAISSE DE DEPOT ET PLACEMENT DU QUEBEC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.84M sh
Reported value held$273.63M
Portfolio Weight0.40%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How CAISSE DE DEPOT ET PLACEMENT DU QUEBEC's GILD position evolved

CAISSE DE DEPOT ET PLACEMENT DU QUEBEC first disclosed a stake in GILD in Q3 2023 at 3,186,159 shares (US$238.8M). The position peaked in Q3 2026 at 1,835,851 shares, worth US$273.6M. Across 13 filings, CAISSE DE DEPOT ET PLACEMENT DU QUEBEC increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,835,851 shares valued at US$273.6M — a reduction of -247,539 shares quarter over quarter.. Notable position changes include a 68% trim in Q2 2024 (shares rose 22% over the following quarter), a 149% increase in Q4 2024 (shares rose 21% over the following quarter), a 63% increase in Q1 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.19M $238.77M New
Q4 2023 2.30M $186.18M Reduce
Q1 2024 1.70M $124.73M Reduce
Q2 2024 547.32K $37.55M Reduce
Q3 2024 411.73K $34.52M Reduce
Q4 2024 1.03M $94.75M Add
Q1 2025 1.55M $173.37M Add
Q2 2025 1.37M $151.83M Reduce
Q3 2025 1.27M $141.08M Reduce
Q4 2025 949.45K $116.54M Reduce
Q1 2026 1.54M $215.22M Add
Q2 2026 2.08M $263.22M Add
Q3 2026 1.84M $273.63M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has CAISSE DE DEPOT ET PLACEMENT DU QUEBEC held GILD?

CAISSE DE DEPOT ET PLACEMENT DU QUEBEC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAISSE DE DEPOT ET PLACEMENT DU QUEBEC's current position in GILD?

As of Q3 2026, CAISSE DE DEPOT ET PLACEMENT DU QUEBEC holds 1.84M shares of GILD (GILEAD SCIENCES INC), valued at $273.63M, representing 0.40% of its reported portfolio and ranking #49.

Has CAISSE DE DEPOT ET PLACEMENT DU QUEBEC been buying or selling GILD?

In the latest 13F filing (Q3 2026), CAISSE DE DEPOT ET PLACEMENT DU QUEBEC reduced its position in GILD. The position peaked in Q3 2026 at 1.84M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.